---
outcome: success
failure_modes:
  - wrong_pattern
reviewed_by: codex
reviewed_at: "2026-05-16"
---

## Summary

This attempt correctly addresses the fibrocyte revision and is byte-identical to
eval PR #59. It updates the label to circulating fibrocyte, replaces the
definition, adds the monocyte-derived fibrocyte narrow synonym, removes the
stale tendon-cell inferred parent, and changes the developmental origin to the
myeloid-lineage-restricted progenitor cell used in the gold PR.

The remaining gap is modeling form: it keeps the class fully defined where the
human PR made it primitive.

## Strengths

The core biological correction is right. The old inactive-fibroblast definition
is gone, the term is placed as a stromal/progenitor cell, and the new capability
axioms include antigen presentation, wound healing, and positive regulation of
angiogenesis.

The attempt also preserves "fibrocyte" as an exact synonym, which is useful
after the label is changed to the more specific circulating fibrocyte.

## Issues

The accepted PR removed the `EquivalentClasses` axiom and asserted the
differentiae as primitive `SubClassOf` axioms. Keeping a full equivalence is a
stronger modeling pattern and is the main reason the otherwise good attempt
diverges from gold.

It also rewrites the long marker comment and adds issue-link provenance that the
human PR did not include. Those are reasonable edits in isolation, but the issue
had deferred the comment cleanup.
